IP Library Granted Patent US 10,118,996
Granted Patent B2
US 10,118,996 · App. 13/774,302 · Granted Nov 6, 2018

Polyrotaxanes and uses thereof

Inventors: David H. Thompson (West Lafayette, IN); Seok-Hee Hyun (West Lafayette, IN); Kyle J. Wright (West Lafayette, IN)
Assignee: Purdue Research Foundation
C08G83/007C08B37/0012C08B37/0015C08H1/00G01N33/58
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,118,996
App. No.
13/774,302
Granted
Nov 6, 2018
Kind
B2
Abstract

A polyrotaxane containing an affinity binding group has been designed and prepared. The polyrotaxane of the invention can be used for characterization and determination of the three-dimensional structures of biological molecules, such as proteins.

Claims (17)

1. A polyrotaxane comprising a plurality of macrocyclic molecules, a linear axle molecule threading through the macrocyclic molecules, and a capping group at each end of the linear axle molecule, wherein one or more of the macrocyclic molecules comprise an affinity binding group and wherein the macrocyclic molecules are laterally and rotationally mobile along the linear axle molecule, wherein the affinity binding group is a metal chelate having a chelating agent moiety and a metal ion, wherein the capping group is linked to the linear moiety through a bond,

wherein said metal ion is Ni 2+ , and

wherein the polyrotaxane has the following structure

wherein x is 113; m is 17; and n is 1.1.

2. A method of characterizing or determining a three-dimensional structure of a biological molecule, comprising the steps of

(a) contacting a polyrotaxane with the biological molecule to form a complex;

(b) subjecting the complex to cryogenic electron microscopy; and

(c) analyzing data collected from the cryogenic electron microscopy experiment wherein said polyrotaxane comprises a plurality of macrocyclic molecules, a linear axle molecule threading through the macrocyclic molecules, and a capping group at each end of the linear axle molecule, wherein one or more of the macrocyclic molecules comprise an affinity binding group and wherein the macrocyclic molecules are laterally and rotationally mobile along the linear axle molecule, wherein the affinity binding group is a metal chelate having a chelating agent moiety and a metal ion, wherein the capping group is linked to the linear moiety through a bond, and

wherein said metal ion is Ni 2+ ;

wherein the polyrotaxane has the following structure

wherein x is 113; m is 17; and n is 1.1.

3. The method of claim 2 , wherein the biological molecule is a protein, a lipid, a nucleic acid, an oligosaccharide, or a complex thereof.

4. The method of claim 2 , wherein the biological molecule is a protein or a complex thereof.

5. The method of claim 2 , wherein the ratio of the number of the biological molecule to the number of the macrocyclic molecules is from about 1:6 to about 1:1.

6. The method of claim 2 , wherein the polyrotaxane is a crosslinked polyrotaxane.

7. The method of claim 6 , wherein the crosslinked polyrotaxane is in the form of a thin membrane for specific capture of affinity tagged biological molecules.

8. The method of claim 7 , wherein the thin membrane is deposited on TEM grids.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 2, 2013
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030130/0391 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2013
From: THOMPSON, DAVID H; HYUN, SEOK-HEE; WRIGHT, KYLE
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 029952/0169 →
Continuity (2)
Provisional Application 61602835 · Feb 24, 2012
Related Publication 20130224881A1 · Aug 29, 2013